A. Franke

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Michael Herold, Antina Schulze, Dietger Niederwieser et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 103 citations · Full text

Medicine, Oncology, Pharmacology +14

Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

Martin Mohren, Ilka Markmann, Kathleen Jentsch‐Ullrich et al. · British Journal of Cancer · 2005 · 78 citations · Full text

Medicine, Hematology, Oncology +14

Increased risk of venous thromboembolism in patients with acute leukaemia

Martin Mohren, Ilka Markmann, Kathleen Jentsch‐Ullrich et al. · British Journal of Cancer · 2006 · 66 citations · Full text

Medicine, Hematology, Oncology +11

Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study

Manfred Heim, M.R. Clemens, W. Queißer et al. · Onkologie · 2009 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +15

Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab

Michael Herold, Gottfried Dölken, F. Fiedler et al. · Annals of Hematology · 2003 · 50 citations

Medicine, Oncology, Pharmacotherapy +14